¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"factor III"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
factor IIa
factor II
factor I
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
factor III
Á¦3ÀÎÀÚ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
antihemophilic factor
Ç×Ç÷¿ìº´ÀÎÀÚ
antineuritic factor
Ç׽Ű濰ÀÎÀÚ
antipellagra factor
Çׯç¶ó±×¶óÀÎÀÚ
antiphagocytic factor
Çׯ÷½ÄÀÎÀÚ, Ç׎½ÄÀÎÀÚ
antiplatelet factor
Ç×Ç÷¼ÒÆÇÀÎÀÚ
antirachitic factor
Ç×±¸·çº´ÀÎÀÚ
antiscorbutic factor
Ç×±«Ç÷º´ÀÎÀÚ
antisterility factor
Ç׺ÒÀÓÀÎÀÚ
atrial natriuretic factor
½É¹æ³ªÆ®·ýÀÌ´¢ÀÎÀÚ, ½É¹æ¼ÒµãÀÌ´¢ÀÎÀÚ
activation factor
Ȱ¼ºÀÎÀÚ
absorbed dose conversion factor
Èí¼ö¼±·®º¯È¯°è¼ö
alveolar dilution factor
ÆóÆ÷Èñ¼®ÀÎÀÚ, ÇãÆÄ²Ê¸®Èñ¼®ÀÎÀÚ
amplification factor
ÁõÆøÀÎÀÚ
behavioral risk factor
ÇൿÀ§Çè¿äÀÎ
coagulation factor
ÀÀ°íÀÎÀÚ
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
factor
ÀÎÀÚ, ¿äÀÎ, °è¼ö
activation factor
Ȱ¼ºÀÎÀÚ
antiplatelet factor
Ç×Ç÷¼ÒÆÇÀÎÀÚ
coagulation V factor
Á¦5Ç÷¾×ÀÀ°íÀÎÀÚ
exclusion of confounding factor
±³¶õº¯¼ö¹èÁ¦
growth factor
¼ºÀåÀÎÀÚ
intrinsic factor
³»ÀÎÀÎÀÚ, ³»ÀÎÀÚ
nerve growth factor
½Å°æ¼ºÀåÀÎÀÚ
platelet activating factor
Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ
platelet-derived growth factor
Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
precipitation factor
ÃËÁø¿äÀÎ
predisposing factor
¼±Çà¿äÀÎ
prognostic factor
¿¹ÈÄÀÎÀÚ
psychological factor
½É¸®¿ä¼Ò
relaxing factor
ÀÌ¿ÏÀÎÀÚ
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
absorbed dose conversion factor
Èí¼ö¼±·®º¯È¯°è¼ö
activation factor
Ȱ¼ºÀÎÀÚ
alveolar dilution factor
ÆóÆ÷Èñ¼®ÀÎÀÚ, ÇãÆÄ²Ê¸®Èñ¼®ÀÎÀÚ
amplification factor
ÁõÆøÀÎÀÚ
antihemophlic factor
Ç×Ç÷¿ìº´ÀÎÀÚ
antineuritic factor
Ç׽Ű濰ÀÎÀÚ
antipellagra factor
Çׯç¶ó±×¶óÀÎÀÚ
antiphagocytic factor
Çׯ÷½ÄÀÛ¿ëÀÎÀÚ
antirachitic factor
Ç×±¸·íº´ÀÎÀÚ
antiscorbutic factor
Ç×±«Ç÷º´ÀÎÀÚ
antisterility factor
Ç׺ÒÀÓÀÎÀÚ
atrial natriuretic factor
½É¹æ³ªÆ®·ýÀÌ´¢ÀÎÀÚ
colonizing factor antigen
Áý¶ôÇü¼ºÀÎÀÚÇ׿ø
behavioral risk factor
ÇൿÀ§Çè¿äÀÎ
carcinogenic factor
¹ß¾ÏÀÎÀÚ
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
platelet factor III
Ç÷¼ÒÆÇÁ¦»ïÀÎÀÚ.
DSM-III
Á¤½ÅÀå¾Ö(º´)Áø´ÜÅë°èÆí¶÷ Á¦ 3ÆÇ
DSM-III-R
Á¤½ÅÀå¾Ö(º´)Áø´ÜÅë°èÆí¶÷ Á¦ 3ÆÇ °³Á¤ÆÇ
Sudan III
¼ö´Ü III
antithrombin III
Çׯ®·Òºó III
apolipoprotein C-III
¾ÆÆ÷Áö´Ü¹é C-III
arsenazo III dye
¾Æ¸£¼¼³ªÁ¶<ºñ¼Ò¾ÆÁ¶> III ¿°·á
group III fiber
Á¦¥²¤Çí·A.
group III fiber
Á¦¥²±º¼¶À¯(ÏØàéë«).
hyperlipoproteinemia type III
°íÁö´Ü¹éÇ÷Áõ III
hyperproteinemia type III
´Ü¹é°úÀ×Ç÷(Áõ) III Çü
hypersensitivity reactions,type iii(imune complex-mediated)
IIIÇü
procollagen III peptide
ÇÁ·ÎÄݶó°Õ III ÆéƼµå
pseudounipolar(bipolar III) disorder
°¡¼º ´Ü±Ø¼º(¾ç±Ø¼º III)Àå¾Ö(º´).
F factor (fertility factor)
FÀÎÀÚ, ¼öÅÂÀÎÀÚ
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
platelet factor III
Ç÷¼ÒÆÇÁ¦»ïÀÎÀÚ.
antithrombin III
Çׯ®·Òºó III
apolipoprotein C-III
¾ÆÆ÷Áö´Ü¹é C-III
arsenazo III dye
¾Æ¸£¼¼³ªÁ¶<ºñ¼Ò¾ÆÁ¶> III ¿°·á
group III fiber
Á¦¥²±º¼¶À¯(ÏØàéë«).
group III fiber
Á¦¥²¤Çí·A.
hyperlipoproteinemia type III
°íÁö´Ü¹éÇ÷Áõ III
hyperproteinemia type III
´Ü¹é°úÀ×Ç÷(Áõ) III Çü
hypersensitivity reactions,type iii(imune complex-mediated)
IIIÇü
oculomotor nerve (iii)
´«µ¹¸²½Å°æ
os metacarpale III ³ª
¼Â°¼Õ¹Ù´Ú<Áß¼ö>»À, Á¦»ïÁß¼ö°ñ(ð¯ß²ñéâ¢Íé).
procollagen III peptide
ÇÁ·ÎÄݶó°Õ III ÆéƼµå
pseudounipolar(bipolar III) disorder
°¡¼º ´Ü±Ø¼º(¾ç±Ø¼º III)Àå¾Ö(º´).
third arch (iii)
¼Â°±ÁÀÌ
type III human T lymphotropic virus
IIIÇü ÀÎ t¸²ÇÁ¿µ¾ç¼º ¹ÙÀÌ·¯½º
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½